drugset / Trial / NCT02369159
Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will evaluate the safety, pharmacokinetics and effectiveness of a single dose of IV peramivir compared to a standard 5 day course of oral oseltamivir in the treatment of pediatric subjects with acute uncomplicated influenza.
Timeline
- Start
- 2015-03-11
- Primary completion
- 2019-10-28
- Completion
- 2020-05-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Oseltamivir | Small molecule | 75 mg | Oral |
| Subject | PERAMIVIR ANHYDROUS | Small molecule | 8 mg/kg | Intravenous |
| Subject | PERAMIVIR ANHYDROUS | Small molecule | 12 mg/kg | Intravenous |
| Subject | PERAMIVIR ANHYDROUS | Small molecule | 600 mg | Intravenous |